Ignite Creation Date:
2025-12-25 @ 2:48 AM
Ignite Modification Date:
2026-01-01 @ 2:00 AM
Study NCT ID:
NCT01938833
Status:
TERMINATED
Last Update Posted:
2025-05-16
First Post:
2013-09-05
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Romidepsin and Abraxane in Treating Patients With Metastatic Inflammatory Breast Cancer
Sponsor:
Sidney Kimmel Cancer Center at Thomas Jefferson University
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2014-04
Start Date Type:
ACTUAL
Primary Completion Date:
2016-08-18
Primary Completion Date Type:
ACTUAL
Completion Date:
2016-12-08
Completion Date Type:
ACTUAL
First Submit Date:
2013-09-05
First Submit QC Date:
None
Study First Post Date:
2013-09-10
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2017-09-05
Results First Submit QC Date:
None
Results First Post Date:
2017-09-29
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-05-14
Last Update Post Date:
2025-05-16
Last Update Post Date Type:
ACTUAL